Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

[1] Ahmadzadehfar H(2011)  Eur J Nucl Med Mol Imaging 38 1281-1288

[2] Sabet A(2008)Tc-MAA/ J Clin Oncol 26 5910-5917

[3] Muckle M(2013)Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/ Eur J Cancer 49 3122-3130

[4] Wilhelm K(2009)Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization Cardiovasc Intervent Radiol 32 727-736

[5] Reichmann K(2001)Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials Oncologist 6 56-64

[6] Biersack HJ(2011)Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study Am J Clin Oncol 34 337-341

[7] Ezziddin S(2010)Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings Br J Cancer 103 324-331

[8] Arkenau HT(2004)The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer N Engl J Med 351 337-345

[9] Arnold D(2011)General selection criteria of patients for radioembolization of liver tumors: an international working group report Med Phys 38 4824-4845

[10] Cassidy J(2013)Multicentre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases Lancet Oncol 14 269-270

[1] Ahmadzadehfar H(2011)  Eur J Nucl Med Mol Imaging 38 1281-1288

[2] Sabet A(2008)Tc-MAA/ J Clin Oncol 26 5910-5917

[3] Muckle M(2013)Y-Bremsstrahlung SPECT/CT after simultaneous Tc-MAA/ Eur J Cancer 49 3122-3130

[4] Wilhelm K(2009)Y-microsphere injection for immediate treatment monitoring and further therapy planning for radioembolization Cardiovasc Intervent Radiol 32 727-736

[5] Reichmann K(2001)Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials Oncologist 6 56-64

[6] Biersack HJ(2011)Radioembolisation for liver metastases: results from a prospective 151 patient multi-institutional phase II study Am J Clin Oncol 34 337-341

[7] Ezziddin S(2010)Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings Br J Cancer 103 324-331

[8] Arkenau HT(2004)The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer N Engl J Med 351 337-345

[9] Arnold D(2011)General selection criteria of patients for radioembolization of liver tumors: an international working group report Med Phys 38 4824-4845

[10] Cassidy J(2013)Multicentre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases Lancet Oncol 14 269-270